Non-nucleoside reverse transcriptase inhibitors - PDFSEARCH.IO - Document Search Engine

Non-nucleoside reverse transcriptase inhibitors
Results: 253

#	Item
201	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use EDURANT® safely and effectively. See full prescribing information for EDURANT. EDURANT (rilpivirine) tablets for or Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2014-05-02 15:03:35 Carbamates Protease inhibitors Pyrimidines Nitriles Rilpivirine Darunavir Efavirenz Etravirine Delavirdine Organic chemistry Chemistry Non-nucleoside reverse transcriptase inhibitors
202	AIDS InfoNet www.aidsinfonet.org Fact Sheet Number 001A Add to Reading List Source URL: www.aidsinfonet.org Language: English - Date: 2013-09-05 09:42:15 Organic chemistry Gilead Sciences Organofluorides Cyclopropanes Non-nucleoside reverse transcriptase inhibitors Antiretroviral drug Emtricitabine Reverse-transcriptase inhibitor AIDS HIV/AIDS Chemistry Medicine
203	AIDS InfoNet www.aidsinfonet.org Fact Sheet Number 001A Add to Reading List Source URL: www.aidsinfonet.org Language: English - Date: 2013-09-05 09:42:15 Organic chemistry Gilead Sciences Organofluorides Cyclopropanes Non-nucleoside reverse transcriptase inhibitors Antiretroviral drug Reverse-transcriptase inhibitor Emtricitabine AIDS HIV/AIDS Chemistry Medicine
204	The United States President’s Emergency Plan for AIDS Relief Bringing Hope: Supplying Antiretroviral Drugs for HIV/AIDS Treatment Add to Reading List Source URL: www.state.gov Language: English - Date: 2014-08-02 19:44:55 Bristol-Myers Squibb Cyclopropanes Non-nucleoside reverse transcriptase inhibitors Organofluorides Nevirapine Stavudine Antiretroviral drug Lamivudine Efavirenz Chemistry Organic chemistry Pharmacology
205	January 5, [removed]Vol[removed]Nos. 51 &[removed]Serious Adverse Events Attributed to Nevirapine Regimens for Postexposure Prophylaxis After HIV Exposures — Worldwide, 1997–2000 Add to Reading List Source URL: www.cdc.gov Language: English - Date: 2001-08-06 10:02:32 HIV/AIDS Medical terms Ketones Cyclopropanes Non-nucleoside reverse transcriptase inhibitors Post-exposure prophylaxis Nevirapine Antiretroviral drug AIDS Medicine Health Chemistry
206	Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Tuberculosis Elimination Add to Reading List Source URL: www.cdc.gov Language: English - Date: 2013-10-30 10:15:46 Tuberculosis Organofluorides Non-nucleoside reverse transcriptase inhibitors Cyclopropanes Rifamycin antibiotics Efavirenz Nevirapine Tuberculosis treatment Antiretroviral drug Chemistry Organic chemistry Medicine
207	Please note: An erratum has been published for this issue. To view the erratum, please click here. Morbidity and Mortality Weekly Report Recommendations and Reports November 22, [removed]Vol[removed]No. RR-18 Add to Reading List Source URL: www.cdc.gov Language: English - Date: 2002-11-27 11:42:19 Medicine Cyclopropanes Non-nucleoside reverse transcriptase inhibitors Protease inhibitors Azides Zidovudine Antiretroviral drug HIV AIDS Chemistry Organic chemistry HIV/AIDS
208	HIV Resistance Collaborative Group Data Analysis Plan for Resistance Add to Reading List Source URL: www.fda.gov Language: English - Date: 1999-10-29 04:20:00 Purines Organofluorides Non-nucleoside reverse transcriptase inhibitors Bristol-Myers Squibb Reverse-transcriptase inhibitor Antiretroviral drug Lamivudine Nevirapine Efavirenz Chemistry Organic chemistry Cyclopropanes
209	1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use EDURANT safely and effectively. See full prescribing information for EDURANT. Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2011-05-20 11:23:31 Carbamates Protease inhibitors Pyrimidines Nitriles Rilpivirine Efavirenz Darunavir Etravirine Reverse-transcriptase inhibitor Chemistry Organic chemistry Non-nucleoside reverse transcriptase inhibitors
210	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use COMPLERA safely and effectively. See full prescribing information for COMPLERA. • Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2014-06-10 15:35:43 Fixed dose combination Pharmacology Non-nucleoside reverse transcriptase inhibitors Bristol-Myers Squibb Organofluorides Tenofovir Emtricitabine/tenofovir/efavirenz Emtricitabine Efavirenz Gilead Sciences Chemistry Organic chemistry

UPDATE